DAPAGLIFLOZIN
Clinical Indication
Chronic Heart failure with reduced ejection fraction or mildly reduced ejection fraction
Comments
For prescribers who feel competent, in line with the updated LLR HF guide; others should refer back to specialist services
In line with NICE TA902 and NICE TA679
Date of classification
July 2026
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.